Identify biomarkers with trustworthy, explainable AI.
Understand disease by revealing important disease mechanisms.
Proven team, technology, and results.
Abzu delivers groundbreaking biomarker identification and validation for pharma, biotech, and research institutions.
Pioneering in novel biomarkers.
Innovative insights into disease pathways, interactions, and mechanisms.
We’re transforming the landscape of disease understanding through our specialized workflow to identify biomarkers.
We decode the complex language of diseases through our trustworthy, explainable AI, advanced analysis, and research techniques, offering a more comprehensive understanding of pathological processes.
Abzu’s measurable impact in identifying biomarkers.
Where proven results speak louder than promises, Abzu stands apart.
Abzu is your partner in identifying novel biomarkers.
A cycle of discovery and validation — to realization.
Whether we start by understanding disease status from data or validating candidates through designed experiments, Abzu provides you the the insights and confidence to accelerate your R&D and discover novel biomarkers with ease.
The latest in research, perspective, and events.
Your next biomarker insight starts here.
Abzu’s Jonas Elsborg presents his research with NASA GeneLab: “Elucidating dermatological changes in spaceflight with explainable AI.”
We brought data-driven insights to expectant parents at important stages of pregnancy to reduce the risk inherent in vaginal or caesarian delivery.
Project Elegant North will create a cross-border, rare disease data-sharing platform to foster cross-sector collaboration between researchers, companies, and healthcare systems.
Less data, more discovery.
Make the most out of every piece of information.
Contrary to the data-heavy demands of black-box AI, our technology thrives on minimal data. This efficiency not only accelerates the discovery process, but also reduces your barrier to entry to understand diseases and disease mechanisms.
Let's understand disease together.
But first: Tell us about your scientific and business objectives.
Let’s have a conversation about your targets, therapies, and goals. If you want to transcend insufficient analytics and black-box AI, then please complete the form below — we look forward to chatting!
Abzu is making headlines.
Abzu's innovative work in disease understanding makes waves in the scientific community and beyond.
Pharmafocus
February 7, 2024
Don’t settle for black box: Why only explainable AI is built for pharma.
IPT
June 12, 2023
AI in Pharma: Balancing Reality with Possibility.
Sifted
May 5, 2023
20 Nordic startups to watch, according to investors.
OTS
May 9, 2022
Could Artificial Intelligence Provide the Key to Life Saving Medicines?
Subscribe for
notifications from Abzu.
